@article {666899,
	title = {Expansion of Private Equity Involvement in Women{\textquoteright}s Health Care},
	journal = {JAMA Internal Medicine},
	volume = {180},
	number = {11},
	year = {2020},
	pages = {1542{\textendash}1545},
	abstract = {
	We document formerly non{\textendash}private equity women{\textquoteright}s health care companies, including physician networks, practices, and fertility clinics, that gained a private equity affiliation between 2010 and 2019. This analysis\&nbsp;shows a substantial increase in private equity affiliations in women{\textquoteright}s health care since 2017. Private equity{\textendash}affiliated OB/GYN offices are located in urban locations, with an average 2017 median household income 24\% higher than the 2017 national average.\&nbsp;How the incentives of private equity firms interact with the clinical mission of women{\textquoteright}s health is a critical area of inquiry. Future debate about private equity in women{\textquoteright}s health will likely be shaped by the associations between economic incentives and quality of care, elective or cosmetic procedures, and access to reproductive health services, especially among low-income, LGBTQIA, and other disadvantaged populations.



	Commentary:\&nbsp;Private Equity, Women{\textquoteright}s Health, and the Corporate Transformation of American Medicine

},
	url = {doi:10.1001/jamainternmed.2020.3567},
	author = {Joseph D. Bruch and Alexander Borsa and Zirui Song and Sarah S. Richardson}
}
